GLP-1 clinical trials enrolling now. Find one near you.
78 GLP-1 clinical trials covering 54 conditions are recruiting across 46 US states as of August 29, 2026. You pay nothing for the medication.
In every clinical trial here, the study medication and trial visits cost you nothing, and many pay you for your time. Some participants get a placebo, assigned at random.
- A study testing whether a new weekly shot from Lilly, retatrutide, can help people reduce liver fat.Enrolling
- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH), BMI 25+.
- Where
- Alabama, Arizona and 33 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Children and teens 8 to 18, are overweight.
- Where
- California, Florida and 17 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a study medicine from Novo Nordisk, cagrisema, can help people lose weight.Enrolling
- Who can join
- Adults 18+, have obesity, BMI 35+.
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH), BMI 25+.
- Where
- Arizona, California and 23 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 23+.
- Where
- Alabama, Arizona and 29 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.Enrolling
- Who can join
- Children and teens 6 to 17, have obesity.
- Where
- Arizona, California and 27 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have peripheral artery disease (poor blood flow in the legs), BMI 23+.
- Where
- Alabama, Arizona and 12 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people ease joint pain.Enrolling
- Who can join
- Adults 18+, have osteoarthritis (joint pain), BMI 27+.
- Where
- Arizona, California and 15 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, women only, have stress urinary incontinence (bladder leaks), BMI 27+.
- Where
- Alabama, Arizona and 9 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 35+.
- Where
- Arizona, Arkansas and 17 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 99, have obesity or are overweight, BMI 25+.
- Where
- Alabama, Arizona and 16 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have ulcerative colitis, BMI 27+.
- Where
- Alabama, California and 21 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have Crohn's disease, BMI 27+.
- Where
- Alabama, California and 20 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 23+.
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity, BMI 27+.
- Where
- Arizona, California and 20 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes, BMI 27+.
- Where
- Arizona, California and 12 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes.
- Where
- Alabama, California and 12 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.Enrolling
- Who can join
- Children and teens 12 to 17, have obesity.
- Where
- California, Connecticut and 8 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have obesity, BMI 30+.
- Where
- Alabama, California and 15 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot from Lilly, tirzepatide, can help people calm psoriasis.Enrolling
- Who can join
- Adults 18+, have psoriatic arthritis, BMI 27+.
- Where
- Arizona, California and 15 more states
Study details
View on ClinicalTrials.gov → - A study testing whether a new weekly shot from Lilly, tirzepatide, can help people calm psoriasis.Enrolling
- Who can join
- Adults 18+, have psoriasis, BMI 27+.
- Where
- Arizona, California and 20 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 75, have type 2 diabetes.
- Where
- California, Florida and 9 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, are overweight, BMI 27+.
- Where
- Alabama, California and 10 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot from Lilly, tirzepatide, can help people lose weight.Enrolling
- Who can join
- Children and teens 12 to 17, have obesity.
- Where
- California, Delaware and 6 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 80, have alcohol use disorder, BMI 21+.
- Where
- California, Florida and 12 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have chronic kidney disease, BMI 27+.
- Where
- California, Colorado and 9 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have type 2 diabetes, BMI 25+.
- Where
- Alabama, California and 6 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 40 to 80, have type 2 diabetes.
- Where
- Alabama, Arizona and 23 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 65, have nausea and vomiting, BMI 25+.
- Where
- California, Florida and 4 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 65 to 100, have obesity or are overweight, BMI 35+.
- Where
- Arizona, Florida and 8 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 27+.
- Where
- Arizona, California and 3 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have fatty liver disease (also called MASH or NASH), BMI 30+.
- Where
- California, Louisiana and 1 more state
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 30+.
- Where
- California, Florida and 4 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity or are overweight, BMI 27+.
- Where
- California, Florida and 1 more state
Study details
View on ClinicalTrials.gov →- A study testing whether a study medicine from Novo Nordisk, cagrisema, can help people lose weight.Enrolling
- Who can join
- Adults 18 to 65, have obesity, BMI 30+.
- Where
- Florida and Louisiana
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have opioid use disorder, BMI 23+.
- Where
- Florida, Illinois and 5 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes.
- Where
- Texas
Study details
View on ClinicalTrials.gov →- A study of a GLP-1 medicine, orforglipron, in people with endometrioid endometrial adenocarcinoma.Enrolling
- Who can join
- Adults 18+, women only, have endometrioid endometrial adenocarcinoma, BMI 30+.
- Where
- Florida
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 49, have type 1 diabetes, BMI 20+.
- Where
- Colorado and Washington
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity or are overweight, BMI 30+.
- Where
- Arizona and Illinois
Study details
View on ClinicalTrials.gov →- Who can join
- Ages 12 to 35, women only, have polycystic ovary syndrome (PCOS), BMI 27+.
- Where
- Colorado
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 65+, women only, have type 2 diabetes, BMI 27+.
- Where
- Georgia
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 65, have obesity or are overweight, BMI 30+.
- Where
- Minnesota
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot, tirzepatide, may help during breast cancer treatment.Enrolling
- Who can join
- Adults 18+, have hormone-receptor-positive breast cancer, BMI 27+.
- Where
- New Jersey
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 40 to 85, are joining a healthy-aging study, BMI 22+.
- Where
- Illinois
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have opioid use disorder, BMI 18+.
- Where
- Maryland, Massachusetts and 2 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 45 to 55, women only, are going through menopause.
- Where
- Colorado, North Carolina and 1 more state
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 21 to 65, are trying to quit smoking, BMI 25+.
- Where
- California, Colorado and 2 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 60, have obesity or are overweight, BMI 25+.
- Where
- Arizona
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 25+.
- Where
- California
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have alcohol use disorder, BMI 23+.
- Where
- Massachusetts
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis), BMI 35+.
- Where
- Arizona, Indiana and 2 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 65, are overweight, BMI 27+.
- Where
- New Jersey
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity, BMI 27+.
- Where
- Texas
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine, semaglutide, can help people protect their kidneys.Enrolling
- Who can join
- Adults 20+, have chronic kidney disease.
- Where
- California and Utah
Study details
View on ClinicalTrials.gov → - Who can join
- Ages 12 to 21, have obesity.
- Where
- Virginia
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 21 to 65, have alcohol use disorder, BMI 27+.
- Where
- California
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+.
- Where
- Alabama
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have melanoma.
- Where
- Pennsylvania
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have obesity, BMI 27+.
- Where
- California
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 26, have Prader-Willi syndrome, BMI 30+.
- Where
- Minnesota, Tennessee and 1 more state
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 40, have type 1 diabetes, BMI 19+.
- Where
- Florida
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 27+.
- Where
- Massachusetts
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine, semaglutide, can help people protect their kidneys.Enrolling
- Who can join
- Adults 18+, have diabetic kidney disease, BMI 20+.
- Where
- Colorado and Washington
Study details
View on ClinicalTrials.gov → - A study in people with diabetes.Enrolling
- Who can join
- Adults 18+, have diabetes.
- Where
- Florida
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 25 to 70, have type 1 diabetes.
- Where
- Minnesota
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 21 to 100, have metabolic alcohol-associated liver disease, BMI 25+.
- Where
- Maryland
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine, semaglutide, can help people with HIV drink less.Enrolling
- Who can join
- Adults 18 to 89, have HIV, BMI 23+.
- Where
- Tennessee
Study details
View on ClinicalTrials.gov → - A study testing whether a new weekly shot, tirzepatide, can help people calm gut inflammation.Enrolling
- Who can join
- Adults 18 to 80, have Crohn's disease, BMI 25+.
- Where
- California, Missouri and 1 more state
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have obesity or are overweight, BMI 27+.
- Where
- Maryland
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 50+, have obesity, BMI 30+.
- Where
- Texas
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, are survivors of acute lymphoblastic leukemia, BMI 27+.
- Where
- Tennessee
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 80, have atrial fibrillation, BMI 27+.
- Where
- Ohio
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot, tirzepatide, can help people protect their kidneys.Enrolling
- Who can join
- Adults 18 to 65, have polycystic ovary syndrome (PCOS), BMI 27+.
- Where
- Colorado
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 30, have type 1 diabetes, BMI 27+.
- Where
- Connecticut
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have heart failure with preserved ejection fraction.
- Where
- Texas
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have nafld, BMI 27+.
- Where
- Virginia
Study details
View on ClinicalTrials.gov →
How this directory works
The data comes from ClinicalTrials.gov, the US federal registry for clinical research. We pull active and pre-active GLP-1 clinical trials (semaglutide, tirzepatide, liraglutide, retatrutide, survodutide, orforglipron, cagrisema and related molecules) plus studies of GLP-1 effects on conditions like obesity, type 2 diabetes, MASH, sleep apnea, CKD, and cardiovascular disease.
Every Monday we check these listings against ClinicalTrials.gov. Before you contact a site, click through to its registry record and confirm the clinical trial is still recruiting. For the wider picture on getting a GLP-1 at no cost, see how to get a GLP-1 for free.
How to enroll in a clinical trial
- Find a clinical trial below or take the matching quiz. Read the eligibility criteria. The key inclusion and exclusion items are the ones the trial coordinator will check first.
- Find a site location near you. We list every US site with city, state, and contact information when the sponsor publishes it.
- Contact the site directly using the phone or email on the trial page. Tell them you read about the trial on GLP Chart and you want to be screened.
- Screening typically involves a phone call, a clinic visit, and sometimes blood work. Most clinical trials cover the cost of screening and trial-related medical care. Some sites compensate participants for their time; the trial coordinator explains what each site offers.
- If you do not qualify for the trial you contacted, ask the site coordinator about other clinical trials they run. Many sites run multiple GLP-1 studies at once and can route you to a better fit.
If a trial is not a fit and you need treatment now, the GLP-1 cost guide lays out what every legitimate cash-pay path costs at maintenance dose, starting at $149 a month for compounded semaglutide.
A few legal notes
GLP Chart is not affiliated with any of the sponsors or sites listed. We do not enroll patients in clinical trials, and we are not paid for clinical-trial referrals. If that changes, this page will say so on the day it does.
Participating in a clinical trial is a serious medical decision. Talk to your existing healthcare provider before enrolling. Trial coordinators are required by federal regulation to walk you through informed consent before you join.
Every clinical trial we track
All 90 GLP-1 clinical trials in this directory, including those that have not opened recruitment yet.
Eli Lilly and Company metabolic dysfunction-associated steatotic liver disease clinical trial (NCT07165028), Novo Nordisk A/S overweight clinical trial (NCT07253285), Novo Nordisk A/S obesity clinical trial (NCT07564414), Boehringer Ingelheim metabolic dysfunction associated steatohepatitis clinical trial (NCT06632457), Boehringer Ingelheim metabolic dysfunction associated steatohepatitis (MASH) clinical trial (NCT06632444), Boehringer Ingelheim type 2 diabetes clinical trial (NCT07754461), Eli Lilly and Company obesity clinical trial (NCT06672549), Eli Lilly and Company peripheral arterial disease clinical trial (NCT07223593), Eli Lilly and Company osteoarthritis clinical trial (NCT07153471), Novo Nordisk A/S diabetes mellitus type 2 clinical trial (NCT07282613), Eli Lilly and Company urinary incontinence stress clinical trial (NCT07202884), Kailera obesity clinical trial (NCT07284979), Amgen obesity or overweight clinical trial (NCT07575399), Eli Lilly and Company ulcerative colitis clinical trial (NCT06937086), Eli Lilly and Company Crohn's disease clinical trial (NCT06937099), AstraZeneca type 2 diabetes mellitus clinical trial (NCT07662213), Eli Lilly and Company diabetes mellitus type 2 clinical trial (NCT07668336), Novo Nordisk A/S overweight clinical trial (NCT07668414), Eli Lilly and Company obesity clinical trial (NCT06143956), Eli Lilly and Company type 2 diabetes clinical trial (NCT06897475), Novo Nordisk A/S diabetes mellitus type 2 clinical trial (NCT07668388), Eli Lilly and Company obesity clinical trial (NCT06672939), Novo Nordisk A/S obesity clinical trial (NCT07639021), Eli Lilly and Company psoriatic arthritis clinical trial (NCT06864026), Eli Lilly and Company psoriasis clinical trial (NCT06857942), Novo Nordisk A/S diabetes mellitus type 2 clinical trial (NCT07415954), Novo Nordisk A/S overweight clinical trial (NCT07770841), Eli Lilly and Company obesity clinical trial (NCT06439277), VA Office of Research and Development alcohol use disorder clinical trial (NCT07218354), Novo Nordisk A/S chronic kidney disease clinical trial (NCT06717698), Biomea Fusion Inc. type 2 diabetes clinical trial (NCT07502508), Novo Nordisk A/S overweight clinical trial (NCT07745504), Brigham and Women's Hospital type 2 diabetes clinical trial (NCT05390892), Vanda Pharmaceuticals nausea and vomiting clinical trial (NCT07446439), Novo Nordisk A/S obesity clinical trial (NCT07400107), Veru Inc. obesity & overweight clinical trial (NCT07446998), Antag Therapeutics adults with overweight/obesity and type 2 diabetes clinical trial (NCT07724340), Biomed Industries, Inc. obesity and overweight clinical trial (NCT06732245), Regeneron Pharmaceuticals metabolic dysfunction-associated steatotic liver disease (MASLD) clinical trial (NCT07527910), Novo Nordisk A/S obesity clinical trial (NCT07607587), Regeneron Pharmaceuticals overweight or obesity clinical trial (NCT07685808), Novo Nordisk A/S obesity clinical trial (NCT07184086), T. John Winhusen, PhD opioid use disorder clinical trial (NCT06651177), The University of Texas Health Science Center at San Antonio type 2 diabetes (adult onset) clinical trial (NCT06246799), University of Florida endometrioid endometrial adenocarcinoma clinical trial (NCT07107334), University of Colorado, Denver diabetes mellitus type 1 clinical trial (NCT05819138), University of Chicago overweight or obesity clinical trial (NCT06499857), Massachusetts General Hospital obesity clinical trial (NCT07729332), University of Colorado, Denver PCOS (polycystic ovary syndrome) of bilateral ovaries clinical trial (NCT05819853), Emory University diabetes mellitus type 2 clinical trial (NCT07428746), University of Colorado, Denver obesity/therapy clinical trial (NCT07021937), University of Virginia obesity & overweight clinical trial (NCT07298915), Children's Hospital Los Angeles pediatric obesity clinical trial (NCT06934655), Gila Therapeutics, Inc. obesity & overweight clinical trial (NCT07728383), Rutgers, The State University of New Jersey hormone receptor-positive breast cancer clinical trial (NCT06518837), AgelessRx longevity clinical trial (NCT07092618), Milton S. Hershey Medical Center opioid use disorder clinical trial (NCT06548490), University of Colorado, Denver menopause clinical trial (NCT06975111), Novo Nordisk A/S overweight clinical trial (NCT07767175), University of Southern California smoking cessation clinical trial (NCT07602699), Terrestrial Bio, Inc. overweight and/or obesity clinical trial (NCT07673900), Novo Nordisk A/S obesity clinical trial (NCT07225816), Brigham and Women's Hospital alcohol use disorder (AUD) clinical trial (NCT06727331), The Cleveland Clinic metabolic dysfunction-associated steatotic liver disease (MASLD) clinical trial (NCT06374875), Shanghai World Leader Pharmaceutical Co., Ltd. overweight clinical trial (NCT07465965), The University of Texas Health Science Center, Houston obesity clinical trial (NCT06173778), Srinvasan Beddhu chronic kidney diseases clinical trial (NCT05173714), Washington University School of Medicine lower back pain clinical trial (NCT07731256), University of Virginia obesity in children clinical trial (NCT06903923), University of Southern California alcohol use disorder clinical trial (NCT06994338), University of Alabama at Birmingham diabetes mellitus clinical trial (NCT04055428), Dan Zandberg melanoma clinical trial (NCT04114136), Stanford University obesity clinical trial (NCT05912621), Grace Kim Prader-Willi syndrome clinical trial (NCT06901245), AdventHealth Translational Research Institute diabetes mellitus type 1 clinical trial (NCT05478707), Massachusetts General Hospital obesity clinical trial (NCT05933499), University of Washington diabetic kidney disease clinical trial (NCT05822609), Abbott Diabetes Care diabetes mellitus clinical trial (NCT06668935), Mayo Clinic type 1 diabetes clinical trial (NCT06976619), National Institute on Alcohol Abuse and Alcoholism (NIAAA) metabolic alcohol-associated liver disease clinical trial (NCT07046819), Vanderbilt University Medical Center HIV clinical trial (NCT07221214), Washington University School of Medicine Crohn disease (CD) clinical trial (NCT06976853), Johns Hopkins University obesity and overweight clinical trial (NCT06847399), The University of Texas Health Science Center at San Antonio obesity prevention clinical trial (NCT06811324), St. Jude Children's Research Hospital acute lymphoblastic leukemia clinical trial (NCT07228741), The Cleveland Clinic atrial fibrillation clinical trial (NCT06802081), University of Colorado, Denver autosomal dominant polycystic kidney clinical trial (NCT06582875), Yale University diabetes type 1 clinical trial (NCT06411210), University of Texas Southwestern Medical Center HFpEF - heart failure with preserved ejection fraction clinical trial (NCT07223242), University of Virginia NAFLD clinical trial (NCT05424003)
